Ultra-high performance supercritical fluid chromatography coupled to tandem mass spectrometry for antidoping analyses: Assessment of the inter-laboratory reproducibility with urine samples
Status PubMed-not-MEDLINE Language English Country Germany Media electronic-ecollection
Document type Journal Article
PubMed
38715742
PubMed Central
PMC10989559
DOI
10.1002/ansa.202000131
PII: ANSA202000131
Knihovny.cz E-resources
- Keywords
- anti‐doping analyses, inter‐laboratory reproducibility, tandem mass spectrometry, ultra high‐performance supercritical fluid chromatography,
- Publication type
- Journal Article MeSH
The aim of this study was to assess the interlaboratory reproducibility of ultra-high performance supercritical fluid chromatography coupled with tandem mass spectrometry method for routine antidoping analyses. To do so, a set of 21 doping agents, spiked in urine and analyzed after dilute and shoot treatment, was used to assess the variability of their retention times between four different laboratories, all equipped with the same chromatographic system and with the same ultra-high performance supercritical fluid chromatography stationary phase chemistry. The average relative standard deviations (RSD%) demonstrated a good reproducibility of the retention times for 19 out of 21 analytes, with RSD% values below 3.0%. Only for two substances, namely fenbutrazate and niketamide, the retention was not repeatable between laboratories, with RSD% of approximately 15% in both cases. This behaviour was associated with (a) the low organic modifier percentage (around 2-4%) in the mobile phase at the corresponding retention times, and (b) the influence of the system volume on poorly retained analytes. An analysis on seven "blind" urines was subsequently carried out in the same four laboratories. In these blind samples, either one, two, or none of the 21 doping agents previously analyzed were present at an unknown concentration. Each laboratory had to perform the identification of the compounds in the samples and estimate their concentrations. All laboratories assigned all target analytes correctly in all blind urine samples and provide a comparable estimation of their concentrations.
LABERCA Oniris INRAE Nantes F 44307 France
Waters AG Taefernstrasse 14a Baden Daetwill 5405 Switzerland
See more in PubMed
Iannone M, Botrè F, Martinez‐Brito D, Matteucci R, de la Torre X. Development and application of analytical procedures for the GC–MS/MS analysis of the sulfates metabolites of anabolic androgenic steroids: the pivotal role of chemical hydrolysis. J Chromatogr B. 2020;1155:122280. 10.1016/j.jchromb.2020.122280. PubMed DOI
Jelkmann W. Erythropoietin: novelties in antidoping research. Sports Endocrinol. 2019;9:28‐33. 10.1016/j.coemr.2019.05.005. DOI
Abushareeda W, Vonaparti A, Saad KA, et al. High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis. J Pharm Biomed Anal. 2018;151:10‐24. 10.1016/j.jpba.2017.12.025. PubMed DOI
Liang Y, Liu J, Zhong Q, Huang T, Zhou T. An automatic online solid‐phase dehydrate extraction‐ultra‐high performance supercritical fluid chromatography‐tandem mass spectrometry system using a dilution strategy for the screening of doping agents in human urine. Anal Chim Acta. 2020;1101:184‐192. 10.1016/j.aca.2019.12.011. PubMed DOI
Joseph JF, Parr MK. Chapter 5 ‐ Application of SFC for bioanalysis. In: Ma S, Chowdhury SK, eds. Identif. Quantif. Drugs Metab. Drug Metab. Enzym. Transp. Second Ed.. Amsterdam: Elsevier; 2020:151‐183. 10.1016/B978-0-12-820018-6.00005-3. DOI
Nováková L, Desfontaine V, Ponzetto F, et al. Fast and sensitive supercritical fluid chromatography – tandem mass spectrometry multi‐class screening method for the determination of doping agents in urine. Anal Chim Acta. 2016;915:102‐110. 10.1016/j.aca.2016.02.010. PubMed DOI
Xhaferaj M, Naegele E, Parr MK. Ion exchange in supercritical fluid chromatography tandem mass spectrometry (SFC‐MS/MS): application for polar and ionic drugs and metabolites in forensic and anti‐doping analysis. J Chromatogr A. 2020;1614:460726. 10.1016/j.chroma.2019.460726. PubMed DOI
Losacco GL, Marconetto E, Nicoli R, et al. Supercritical fluid chromatography–mass spectrometry in routine anti‐doping analyses: estimation of retention time variability under reproducible conditions. J Chromatogr A. 2019:460780. 10.1016/j.chroma.2019.460780. PubMed DOI
Nováková L, Rentsch M, Grand‐Guillaume Perrenoud A, et al. Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: analysis of biological samples. Anal Chim Acta. 2015;853:647‐659. 10.1016/j.aca.2014.10.007. PubMed DOI
Nicoli R, Guillarme D, Leuenberger N, et al. Analytical strategies for doping control purposes: needs, challenges, and perspectives. Anal Chem. 2016;88:508‐523. 10.1021/acs.analchem.5b03994. PubMed DOI
Storbeck K‐H, Gilligan L, Jenkinson C, et al. The utility of ultra‐high performance supercritical fluid chromatography–tandem mass spectrometry (UHPSFC‐MS/MS) for clinically relevant steroid analysis. J Chromatogr B. 2018;1085:36‐41. 10.1016/j.jchromb.2018.03.033. PubMed DOI
Lesellier E, West C. The many faces of packed column supercritical fluid chromatography – A critical review. J Chromatogr A. 2015;1382:2‐46. 10.1016/j.chroma.2014.12.083. PubMed DOI
Lesellier E. Retention mechanisms in super/subcritical fluid chromatography on packed columns. Retent Mech Chromatogr Electrophor. 2009;1216:1881‐1890. 10.1016/j.chroma.2008.10.081. PubMed DOI
Schmitz FP, Klesper E. Effect of temperature and mobile phase density on retention and efficiency in supercritical fluid chromatography. J High Resolut Chromatogr. 1987;10:519‐521. 10.1002/jhrc.1240100909. DOI
Dispas A, Marini R, Desfontaine V, et al. First inter‐laboratory study of a supercritical fluid chromatography method for the determination of pharmaceutical impurities. J Pharm Biomed Anal. 2018;161:414‐424. 10.1016/j.jpba.2018.08.042. PubMed DOI
Hegstad S, Havnen H, Helland A, Spigset O, Frost J. Enantiomeric separation and quantification of R/S‐amphetamine in urine by ultra‐high performance supercritical fluid chromatography tandem mass spectrometry. J Chromatogr B. 2018;1077‐1078:7‐12. 10.1016/j.jchromb.2018.01.028. PubMed DOI
Lesellier E, Tchapla A. Retention behavior of triglycerides in octadecyl packed subcritical fluid chromatography with CO2/modifier mobile phases. Anal Chem. 1999;71:5372‐5378. 10.1021/ac990539j. PubMed DOI
Lesellier E. Usual, unusual and unbelievable retention behavior in achiral supercritical fluid chromatography: review and discussion. J Chromatogr A. 2020;1614:460582. 10.1016/j.chroma.2019.460582. PubMed DOI
Grand‐Guillaume Perrenoud A, Hamman C, Goel M, Veuthey J‐L, Guillarme D, Fekete S. Maximizing kinetic performance in supercritical fluid chromatography using state‐of‐the‐art instruments. J Chromatogr A. 2013;1314:288‐297. 10.1016/j.chroma.2013.09.039. PubMed DOI